Anbio Biotechnology Class A Ordinary Shares
NNNN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $2,373 | $2,254 | $10,011 | $2,536 |
| Dep. & Amort. | $0 | $12 | $6 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | $45 | -$1,204 | -$5,530 | $1,646 |
| Other Non-Cash | -$337 | -$163 | -$41 | $0 |
| Operating Cash Flow | $2,080 | $898 | $4,449 | $4,181 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$35,466 | -$18,544 | -$16,090 | $0 |
| Inv. Sales/Matur. | $35,803 | $20,274 | $14,562 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $337 | $1,730 | -$1,528 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$345 | -$43 | $0 | $0 |
| Financing Cash Flow | -$345 | -$43 | $0 | $0 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $2,073 | $2,586 | $2,921 | $4,181 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $9,688 | $7,102 | $4,181 | $0 |
| End Cash | $11,761 | $9,688 | $7,102 | $4,181 |
| Free Cash Flow | $2,080 | $898 | $4,449 | $4,181 |